https://www.stuvia.com/user/performance
Comprehensive Guide to Advanced Pharmacology and
Clinical Practice
Exam Format and Expectations
The NR566 final exam is designed to assess a broad spectrum of knowledge through
100 multiple-choice questions, each valued at 2 points, to be completed within a
150-minute time frame. Only one attempt is permitted, and no support materials are
allowed during the exam. The questions will evaluate various cognitive levels,
including the ability to remember, understand, and apply knowledge in clinical
scenarios. Mastery of both foundational facts and application skills is essential for
success.
Study Guide Usage and Tips
Effective preparation involves active engagement with the material:
Review weekly topics systematically, taking detailed notes.
Rewrite notes to reinforce memory through active learning.
Develop clinical scenario-based practice questions to enhance application skills,
transitioning from rote memorization to practical understanding.
Use multiple senses—reading aloud, listening, and writing—to strengthen
retention.
Regularly review your notes and study guides, ensuring a deep and comprehensive
grasp of the content.
H1 Antagonists and Allergic Rhinitis Management
H1 antagonists, commonly known as antihistamines, are pivotal in managing allergic
reactions. They are classified into first-generation and second-generation agents,
with notable differences in sedative effects and adverse profiles.
, https://www.stuvia.com/user/performance
First-generation H1 antagonists (e.g., diphenhydramine) are sedating, crossing the
blood-brain barrier, leading to sedation and anticholinergic effects such as dry
mouth, urinary retention, and blurred vision.
Second-generation H1 antagonists (e.g., fexofenadine, loratadine) are less sedating
because they minimally cross the blood-brain barrier, making them preferable for
long-term management.
Adverse effects of antihistamines include:
Sedation (more common with first-generation)
Drowsiness
Dry mouth
Dizziness
Potential for anticholinergic effects
Drug-food interactions are notable with agents like fexofenadine, which may have
reduced absorption when taken with fruit juices, necessitating timing considerations.
Intranasal glucocorticoids (e.g., fluticasone) are highly effective for allergic rhinitis,
reducing inflammation directly at the site of allergic response. They are indicated for
persistent symptoms and have minimal systemic absorption but can cause nasal
irritation or dryness.
Cromolyn sodium, an intranasal mast cell stabilizer, prevents the release of
inflammatory mediators and is used for allergic rhinitis, especially in children or as a
prophylactic agent.
Sympathomimetics (e.g., pseudoephedrine) act as decongestants by
vasoconstricting nasal blood vessels. Their mechanisms involve stimulating alpha-
adrenergic receptors, which leads to vasoconstriction and relief of nasal congestion.
However, they carry risks such as:
, https://www.stuvia.com/user/performance
Increased blood pressure
Insomnia
Rebound congestion if overused Other
agents:
Dextromethorphan: antitussive used to suppress cough.
Montelukast: leukotriene receptor antagonist, useful in allergic rhinitis and
asthma.
Ipratropium bromide: anticholinergic nasal spray, reduces rhinorrhea.
Pharmacology of Antipsychotics and Antidepressants
First-generation antipsychotics (FGAs) primarily block dopamine D2 receptors:
Indicated for schizophrenia Provide
positive symptom relief Adverse
effects include:
Extrapyramidal symptoms (EPS), such as dystonia, akathisia, and
Parkinsonism
Tardive dyskinesia, a potentially irreversible movement disorder
Neuroleptic malignant syndrome (NMS), a life-threatening condition
characterized by hyperthermia, rigidity, and altered mental status
Goals of long-term FGA therapy focus on symptom control but require monitoring
for adverse effects.
Second-generation antipsychotics (SGAs) like clozapine:
Have a broader receptor profile, affecting serotonin and dopamine
Are associated with risks such as agranulocytosis (requiring regular blood
monitoring)
Comprehensive Guide to Advanced Pharmacology and
Clinical Practice
Exam Format and Expectations
The NR566 final exam is designed to assess a broad spectrum of knowledge through
100 multiple-choice questions, each valued at 2 points, to be completed within a
150-minute time frame. Only one attempt is permitted, and no support materials are
allowed during the exam. The questions will evaluate various cognitive levels,
including the ability to remember, understand, and apply knowledge in clinical
scenarios. Mastery of both foundational facts and application skills is essential for
success.
Study Guide Usage and Tips
Effective preparation involves active engagement with the material:
Review weekly topics systematically, taking detailed notes.
Rewrite notes to reinforce memory through active learning.
Develop clinical scenario-based practice questions to enhance application skills,
transitioning from rote memorization to practical understanding.
Use multiple senses—reading aloud, listening, and writing—to strengthen
retention.
Regularly review your notes and study guides, ensuring a deep and comprehensive
grasp of the content.
H1 Antagonists and Allergic Rhinitis Management
H1 antagonists, commonly known as antihistamines, are pivotal in managing allergic
reactions. They are classified into first-generation and second-generation agents,
with notable differences in sedative effects and adverse profiles.
, https://www.stuvia.com/user/performance
First-generation H1 antagonists (e.g., diphenhydramine) are sedating, crossing the
blood-brain barrier, leading to sedation and anticholinergic effects such as dry
mouth, urinary retention, and blurred vision.
Second-generation H1 antagonists (e.g., fexofenadine, loratadine) are less sedating
because they minimally cross the blood-brain barrier, making them preferable for
long-term management.
Adverse effects of antihistamines include:
Sedation (more common with first-generation)
Drowsiness
Dry mouth
Dizziness
Potential for anticholinergic effects
Drug-food interactions are notable with agents like fexofenadine, which may have
reduced absorption when taken with fruit juices, necessitating timing considerations.
Intranasal glucocorticoids (e.g., fluticasone) are highly effective for allergic rhinitis,
reducing inflammation directly at the site of allergic response. They are indicated for
persistent symptoms and have minimal systemic absorption but can cause nasal
irritation or dryness.
Cromolyn sodium, an intranasal mast cell stabilizer, prevents the release of
inflammatory mediators and is used for allergic rhinitis, especially in children or as a
prophylactic agent.
Sympathomimetics (e.g., pseudoephedrine) act as decongestants by
vasoconstricting nasal blood vessels. Their mechanisms involve stimulating alpha-
adrenergic receptors, which leads to vasoconstriction and relief of nasal congestion.
However, they carry risks such as:
, https://www.stuvia.com/user/performance
Increased blood pressure
Insomnia
Rebound congestion if overused Other
agents:
Dextromethorphan: antitussive used to suppress cough.
Montelukast: leukotriene receptor antagonist, useful in allergic rhinitis and
asthma.
Ipratropium bromide: anticholinergic nasal spray, reduces rhinorrhea.
Pharmacology of Antipsychotics and Antidepressants
First-generation antipsychotics (FGAs) primarily block dopamine D2 receptors:
Indicated for schizophrenia Provide
positive symptom relief Adverse
effects include:
Extrapyramidal symptoms (EPS), such as dystonia, akathisia, and
Parkinsonism
Tardive dyskinesia, a potentially irreversible movement disorder
Neuroleptic malignant syndrome (NMS), a life-threatening condition
characterized by hyperthermia, rigidity, and altered mental status
Goals of long-term FGA therapy focus on symptom control but require monitoring
for adverse effects.
Second-generation antipsychotics (SGAs) like clozapine:
Have a broader receptor profile, affecting serotonin and dopamine
Are associated with risks such as agranulocytosis (requiring regular blood
monitoring)
